Description
ChemicalBook > CAS DataBase List > PF-05212384

PF-05212384

Description
Product Name
PF-05212384
CAS No.
1197160-78-3
Chemical Name
PF-05212384
Synonyms
CS-46;PKI587;PF-05212384;PKI 587 PF 05212384;GEDATOLISIB;PKI-587;PF-05212384 (PKI-587);PF-05212384 USP/EP/BP;GEDATOLISIB;PF-05212384;PKI-587 ( Gedatolisib );Gedatolisib (PF-05212384, PKI-587)
CBNumber
CB32500950
Molecular Formula
C32H41N9O4
Formula Weight
615.73
MOL File
1197160-78-3.mol
More
Less

PF-05212384 Property

Melting point:
226-227°C
Density 
1.364
storage temp. 
Refrigerator
solubility 
DMSO
pka
13.97±0.70(Predicted)
form 
Solid
color 
Off-White
More
Less

Safety

HS Code 
29349990
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
14567
Product name
PF-05212384
Purity
≥98%
Packaging
1mg
Price
$37
Updated
2024/03/01
Cayman Chemical
Product number
14567
Product name
PF-05212384
Purity
≥98%
Packaging
5mg
Price
$161
Updated
2024/03/01
Cayman Chemical
Product number
14567
Product name
PF-05212384
Purity
≥98%
Packaging
10mg
Price
$283
Updated
2024/03/01
Tocris
Product number
4823
Product name
PF05212384
Purity
≥98%(HPLC)
Packaging
10
Price
$275
Updated
2021/12/16
TRC
Product number
D461135
Product name
N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N''-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-urea
Packaging
50mg
Price
$670
Updated
2021/12/16
More
Less

PF-05212384 Chemical Properties,Usage,Production

Description

Gedatolisib (PF-05212384, PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM in cell-free assays, respectively. Phase 2.

Chemical Properties

Off-White Solid

Uses

This compound shows inhibitory activity against PI3K-α, PI3K-γ and mTOR. Potent PI3K/mTOR Dual Inhibitor.

Biological Activity

pf-05212384 is an inhibitor of pi3k/mtor with ic50 values of 0.4nm, 6nm, 8nm, 6nm and 1.4nm for pi3kα, pi3kβ, pi3kγ, pi3kδ and mtor, respectively [1].pf-05212384 is a pan-pi3k/mtorinhibitor and shows to be highly selective for pi3k and mtor. besides the wt p13k, pf-05212384 can also inhibit mutant p13k with ic50 values of 0.6nm for both h1047r and e545k mutants. in cellular assay, pf-05212384 potently inhibits tumor growth in mda-361 and pc3-mm2 cell lines with ic50 values of 4nm and 13.1nm, respectively. meanwhile, pf-05212384 suppresses the phosphorylation of pi3k/mtor signaling pathway proteins in cells. it inhibits the phosphorylation of akt as well as the akt effector proteins including gsk3 kinase, enos and pras 40. moreover, pf-05212384 has potent anti-tumor activity in a variety of xenograft models including h1975, bt474, hct116, h1975 and u87mg [1, 2]

Enzyme inhibitor

This dual PI3K/mTOR (phosphoinositide-3-kinase and mammalian target of rapamycin) signal-transduction pathway inhibitor and antineoplastic agent (F.Wt. = 615.73; CAS 1197160-78-3); Solubility (25°C): 2 mg/mL DMSO, <1 mg/mL Water), also known as PF-05212384 and systematically as 1-(4- (4-(dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino- 1,3,5-triazin-2-yl)phenyl)urea, inhibits PI3K-α, PI3K-γ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM, respectively. PKI-587 also inhibits mutant forms of PI3Kα, including the PI3Kα-H1047R and PI3Kα-E545K with IC50 of 0.6 nM and 0.6 nM, respectively.

References

[1] venkatesan a m, dehnhardt c m, delos santos e, et al. bis (morpholino-1, 3, 5-triazine) derivatives: potent adenosine 5′-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (pki-587), a highly efficacious dual inhibitor. journal of medicinal chemistry, 2010, 53(6): 2636-2645.
[2] mallon r, feldberg l r, lucas j, et al. antitumor efficacy of pki-587, a highly potent dual pi3k/mtor kinase inhibitor. clinical cancer research, 2011, 17(10): 3193-3203.

PF-05212384 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

PF-05212384 Suppliers

xinguokeji
Tel
13120711461
Email
363372932@qq.com
Country
China
ProdList
491
Advantage
58
Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
94657
Advantage
76
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6005
Advantage
61
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
Fax
0086-571-85864795
Email
sales@capotchem.com
Country
China
ProdList
18207
Advantage
66
JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Fax
86-021-50426522,50426273
Email
sales@jingyan-chemical.com
Country
China
ProdList
9976
Advantage
60
Shanghai Yuanding Chem. Sci. & Tech. Co., Ltd.
Tel
21-57721279
Fax
QQ:14057904
Email
sales@shydchem.com.cn
Country
China
ProdList
982
Advantage
56
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 17702719238
Email
sales@sun-shinechem.com
Country
China
ProdList
960
Advantage
64
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32321
Advantage
50
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Fax
+86 (531) 55696010 QQ 1762738062
Email
sales@trio-pharmatech.com (International market)
Country
China
ProdList
1856
Advantage
62
More
Less

View Lastest Price from PF-05212384 manufacturers

Wuhan Nutra Biotechnology Co.,Ltd
Product
Gedatolisib;PKI-587 1197160-78-3
Price
US $200.00-0.00/g
Min. Order
1g
Purity
98%+
Supply Ability
100kgs
Release date
2021-05-24
Career Henan Chemical Co
Product
PF-05212384 1197160-78-3
Price
US $2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
100kg
Release date
2018-12-24

1197160-78-3, PF-05212384Related Search:


  • PF-05212384
  • PKI587
  • CS-46
  • PKI 587 PF 05212384
  • PF-05212384; PKI587; PKI 587;PKI-587;PF-05212384;PF-05212384
  • GEDATOLISIB;PF-05212384
  • N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]urea
  • 1-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea
  • Gedatolisib (PF-05212384, PKI-587)
  • N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]urea PF-05212384 (PKI-587)
  • PKI-587 N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]urea
  • PKI-587 ( Gedatolisib )
  • GEDATOLISIB;PKI-587
  • GEDATOLISIB (PF-05212384, PKI-587);PKI-587
  • 1-(4-(4-(Dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl
  • PF-05212384 (PKI-587)
  • [(2R)-3-BENZOYLOXY-4,4-DIFLUORO-5-OXOOXOLAN-2-YL]METHYL BENZOATE
  • 1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
  • Urea, N-[4-[[4-(dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-
  • PF-05212384 USP/EP/BP
  • mTOR,Mammalian target of Rapamycin,Inhibitor,PI3K,PF 05212384,Gedatolisib,Phosphoinositide 3-kinase,PKI587,PKI 587,inhibit,PF05212384
  • N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-urea
  • 1197160-78-3
  • C32H41N9O4
  • Akt
  • mTOR
  • PI3K
  • PI3K/Akt/mTOR
  • Inhibitors